How to Help Your Patients Save Money on Fiasp: A Provider's Guide to Savings Programs

Insulin cost is one of the most common barriers to diabetes treatment adherence in the United States. For providers managing patients on Fiasp, understanding the available savings programs and how to access them is as important as the clinical protocol itself. This guide provides a complete overview of Fiasp savings options in 2026 and how your practice can actively support patient access.

The Fiasp Cost Landscape in 2026

Without any assistance, Fiasp can cost $387 or more per 10 mL vial at retail pharmacy prices. However, thanks to the Inflation Reduction Act, Novo Nordisk savings programs, and discount cards, most patients can access Fiasp for significantly less. The challenge is that many patients — especially older adults, those with lower health literacy, and those managing multiple medications — don't know these options exist.

As a provider, a 2-minute conversation or a printed reference card from your office can dramatically change a patient's financial situation and, ultimately, their adherence.

Program 1: Novo Nordisk Savings Card (Commercial Insurance)

The Novo Nordisk Savings Card is available to commercially insured patients (employer, marketplace, or student plans) and provides:

• As little as $35 per 30-day supply (maximum savings of $65 per 30-day supply)
• Covers up to 3 vials or 2 packs of pens per month (up to 35 mL total)
• Includes 1 free pack of pen needles
• Can cover multiple Novo Nordisk insulin products (e.g., Fiasp + Tresiba combined for $35/month)

Enrollment is available at novocare.com or by calling 1-833-992-3299. Patients must re-enroll each calendar year. This program cannot be used by Medicare, Medicaid, or other federal/state insurance beneficiaries.

Provider action: Keep the novocare.com enrollment link (and phone number 1-833-992-3299) available to share at every Fiasp prescription. Consider printing a QR code card for the waiting room.

Program 2: NovoCare Patient Assistance Program (Uninsured/Underinsured)

The Novo Nordisk Patient Assistance Program (PAP) provides Fiasp at no cost to qualifying patients. Your practice's involvement is required: a provider signature on the application is typically needed.

Eligibility criteria:

• No insurance coverage OR insurance that does not cover Fiasp
• Annual income within program limits (proof of household income required)
• US resident with valid prescription

Application: novocare.com or call 1-866-310-7549. Third-party advocates like The Rx Advocates can assist patients with navigating the application process if needed.

Provider action: Identify patients at every Fiasp refill visit who might be uninsured or underinsured. Train your medical assistant to screen for cost-related barriers and initiate the PAP referral workflow.

Program 3: Medicare Part D — IRA Insulin Cap and Price Negotiation

For Medicare patients on Fiasp, 2026 brings important changes:

• IRA Insulin Cap: Under the Inflation Reduction Act, Medicare Part D patients pay no more than $35 per month for covered insulins. Fiasp qualifies.
• Annual OOP Cap: In 2026, a $2,100 out-of-pocket cap applies to all Medicare Part D prescriptions. Once reached, the plan covers medications at no additional cost.
• Negotiated Pricing: Fiasp was selected in 2024 for the first cycle of Medicare price negotiation. Negotiated prices effective from 2026 may further reduce costs for Medicare Part D patients.
• Medicare Extra Help (LIS): Low-income Medicare beneficiaries can apply for the Extra Help program to further reduce Part D premiums, deductibles, and copays. Eligible patients may qualify for minimal or zero cost-sharing.

Provider action: Note that Medicare patients cannot use GoodRx in combination with Medicare benefits. If a Medicare patient is paying more than $35/month for Fiasp, help them confirm their plan covers it under Part D and escalate if needed.

Program 4: GoodRx and SingleCare (All Patients)

Prescription discount cards are available to all patients regardless of insurance status. GoodRx and SingleCare can reduce the cost of Fiasp to approximately $63–$78 per 10 mL vial at participating pharmacies.

Important limitations to communicate to patients:

• GoodRx cannot be combined with any insurance, including Medicare or Medicaid
• Patients choose either GoodRx or their insurance at the pharmacy counter — not both
• Prices vary by pharmacy — GoodRx is useful as a comparison tool to find the lowest local price

Insurance Navigation: Prior Authorization and Tier Exceptions

Some commercial insurance plans place Fiasp on a higher formulary tier or require step therapy before covering it. As the prescriber, you can:

• Submit a prior authorization documenting the clinical necessity of Fiasp (e.g., patient uses CSII and requires ultra-rapid insulin, or tried and failed standard insulin aspart)
• File a formulary exception request to have Fiasp covered at a lower tier
• During the ongoing shortage, cite the shortage as a reason that alternative formats (vials, PenFill) should be covered at parity with the FlexTouch pen

Building a Savings Program Workflow in Your Practice

Consider implementing a simple workflow at every diabetes visit:

1. Screen for cost barriers: Ask every patient on Fiasp whether they've had any trouble affording or finding their insulin
2. Identify their insurance status: Commercial → Savings Card; Uninsured → PAP; Medicare → IRA cap
3. Provide the relevant enrollment link or phone number at checkout
4. Follow up at the next visit to confirm enrollment and that the patient is paying the expected amount

For tools to help your patients locate Fiasp near them, visit medfinder for providers. And for guidance on locating Fiasp during the shortage, see: How to Help Your Patients Find Fiasp in Stock.